Media Centre - IARC NEWS
2013
| Dr John Higginson (1922 - 2013) |
The International Agency for Research on Cancer (IARC) is deeply saddened by the passing away of Dr John Higginson. An internationally esteemed researcher, Dr Higginson had a special place at IARC and was highly appreciated. In July 1966, Dr Higginson was appointed the first director and he played a critical role in shaping the then-nascent Agency with his vision for inter-disciplinary research including epidemiology, biostatistics and laboratory sciences. He served as director of IARC until 1981. Read more , See Photo |
| IARC Fellowships for Cancer Research - Call for applications now open for IARC Fellowships |
| 01/10/2013 - Call for applications now open for IARC Fellowships: - Postdoctoral Fellowship programme - IARC-Australia Postdoctoral Fellowship - IARC-Ireland Postdoctoral Fellowship - Expertise Transfer Fellowship - Senior Visiting Scientist Award Deadline for submission of applications: 30 November 2013 See details |
| New partnership between IARC and CIHCAMS |
| 30/09/2013 - A new partnership agreement has been signed between the International Agency for Research on Cancer (IARC) and the Cancer Institute and Hospital, Chinese Academy of Medical Sciences (CIHCAMS). Read more , See Photos |
| Maurice Tubiana (1920–2013) |
The International Agency for Research on Cancer (IARC) mourns the passing, on 24 September 2013, of the famous French cancer researcher Professor Maurice Tubiana, at the age of 93. Read more |
| EurocanPlatform Session at the European Cancer Congress 2013: Translational research comes of age |
| 23/09/2013 - The European Cancer Congress 2013 Saturday September 28th 14:15 - 15:15 The International Agency for Research on Cancer is happy to participate in this European Union initiative on cancer planning, and Dr Christopher P. Wild will be part of the leading experts who will present engaging discussions regarding two-way translational research, the benefits of genomic stratification and the economics of creating affective clinical trials for new agents. Visit website |
| Two IARC publications highly commended by the British Medical Association |
| 18/09/2013 - Two books published by IARC were shortlisted for the 2013 British Medical Association (BMA) Medical Book Awards and recognized as outstanding contributions to the medical literature. A Review of Human Carcinogens, a six-book package of Volume 100 of the IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, was highly commended in the Public Health category. The panel commented: “This is an important resource in that it defines the current state of evidence-based thinking on cancer-causing agents. It meets its objectives very well and is an authoritative statement from an authoritative body.” WHO Classification of Tumours of the Breast, 4th edition, was highly commended in the Pathology category. The panel commented: “This book is very well-written, easy to read and comprehend. It has the right amount of detail but also covers the topics and includes good quality and relevant illustrations. It has clarity over a range of conditions, some of which are traditionally complex.” Prizes are awarded annually in 21 categories. The BMA judging panel evaluates books for their applicability to the audience, production quality, and originality. This year’s BMA Awards ceremony was held on 17 September. See BMA Medical book awards winners by category |
| IARC Postdoctoral Opportunities - Section of Environment and Radiation |
| 16/09/2013 - Call for applications for a postdoctoral opportunity within the Section of Environment and Radiation Deadline: 20 October 2013 Read More |
| Dr Michael Munishi Oreste Testimonial - First awardee of the UICC-IARC Development Fellowship (2012) - Testimonial |
| 06/09/2013 - Dr Oresto Michael Munishi, Director of the Kilimanjaro Cancer Registry, Kilimanjaro Christian Medical Centre, Moshi, United Republic of Tanzania, received the first awardee of the UICC-IARC Development Fellowship (2012). Read Testimonial |
| IARC Publications - IARC Monographs in PDF |
Volume 104: Malaria and Some Polyomaviruses (SV40, BK, JC, and Merkel Cell Viruses) We are pleased to announce that this volume of the IARC Monographs is now available on-line. Download |
| New IARC breast cancer study in Africa awarded research grant by Susan G. Komen for the Cure |
| 08/08/2013 - The African Breast Cancer Disparities in Outcomes (ABC-DO) study is the first multi-country sub-Saharan African study of breast cancer survival. This four-year research project, led by IARC scientists, aims to understand a woman’s entire breast cancer journey - including determinants of late stage at diagnosis, treatment access and compliance, and ultimately survival - to help prevent avoidable deaths from breast cancer in women in Africa. The study will be conducted in public hospitals in Nigeria, Uganda, South Africa and Namibia. More information |
| IARC Monographs Meeting - Volume 110: Perfluoro-octanoic acid, Tetrafluoroethylene, Dichloromethane, 1,2-Dichloropropane, and 1,3-Propane sultone |
| 03/08/2013 - Volume 110: Perfluoro-octanoic acid, Tetrafluoroethylene, Dichloromethane, 1,2-Dichloropropane, and 1,3-Propane sultone Lyon, France 3-10 June 2014 More information |
| IARC Fellowships for Cancer Research - Next call for applications |
| 26/07/2013 - The next call for applications for IARC Fellowships will be open as from 1st October 2013: - Postdoctoral Fellowship programme - Expertise Transfer Fellowship - Senior Visiting Scientist Award - IARC-Australia Postdoctoral Fellowship - IARC-Ireland Postdoctoral Fellowship Deadline 30 November 2013 Get prepared (contact IARC potential host Group, update your CV, etc.) and keep an eye on our web site! See IARC Fellowships for Cancer Research |
| 12th World Congress of the World Organization for Specialized Studies on Diseases of the Esophagus (OESO) |
IARC is proud to be cooperating for the first time with OESO, the World Organization for Specialized Studies on Diseases of the Esophagus, in the organization of the Paris Congress 2013, to be held from August 27-30, 2013 at the UNESCO Headquarters in Paris. The theme for this year is From normal mucosa to tumor, Translating knowledge into cure. IARC will be represented by Dr Christopher Wild, Director, IARC, and several leading IARC scientists in the fields of Epigenetics and Epidemiology. Link to OESO's website , See announcement |
| IARC Postdoctoral Opportunities - Section of Genetics/Genetic Epidemiology Group |
| 22/07/2013 - Call for applications for two postdoctoral opportunities within the Section of Genetics / Genetic Epidemiology Group. Read More |
| PLoS One - Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica |
A new study by the International Agency for Research on Cancer (IARC), in partnership with Costa Rican investigators and the United States National Cancer Institute (NCI), shows for the first time that the vaccine against human papillomavirus (HPV) types 16 and 18, which is used to prevent cervical cancer, also provides strong protection against oral HPV infections, known to be associated with cancer of the oropharynx and tonsils. R Herrero, W Quint, A Hildesheim, P Gonzalez, L Struijk, H A Katki et al. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One (2013). http://dx.plos.org/10.1371/journal.pone.0068329 Read IARC Press Release 220 Leer IARC Nota de Prensa 220 Read article |
| Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation |
Remarkable progress in the field of epigenetics represents an exciting opportunity to incorporate these new advances into carcinogen identification and safety assessment. A comprehensive search of the Monograph Volume 100 by Dr Z. Herceg and colleagues from the International Agency for Research on Cancer (IARC) revealed that epigenetics have played a modest role in evaluating human carcinogens by the IARC Monographs so far, however epigenetic and epigenomic data might play a pivotal role in the future. We also discuss the issues related to opportunities and challenges in the application of epigenetic testing in carcinogen identification and evaluation. Although the application of epigenetic assays in carcinogen evaluation is still in its infancy, important data are being generated and valuable scientific resources are being established that should catalyze future applications of epigenetic testing. Z Herceg, M-P Lambert, K van Veldhoven, C Demetriou, P Vineis, M T Smith, K Straif and C P Wild Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation Carcinogenesis doi:10.1093/carcin/bgt212 Advance Access published July 13, 2013 Read article |
| Carcinogenicity of some drugs and herbal products |
In June 2013, 23 experts from nine countries met at the International Agency for Research on Cancer (IARC), Lyon, France, to assess the carcinogenicity of 14 drugs and herbal products. Some agents are discussed in more detail because of data complexity or the extent of human exposure. These assessments will be published as Volume 108 of the IARC Monographs. Yann Grosse, Dana Loomis, Béatrice Lauby-Secretan, Fatiha El Ghissassi, Véronique Bouvard, Lamia Benbrahim-Tallaa, Neela Guha, Robert Baan, Heidi Mattock, Kurt Straif, on behalf of the International Agency for Research on Cancer Monograph Working Group The Lancet Oncology Published online July 5, 2013 DOl: 10.1016/S1470-2045(13)70329-2 Read article |
| Paediatric Oncology for Cancer Registries |
| 28/06/2013 - Paediatric Oncology for Cancer Registries 25-29 November 2013 IARC, Lyon, France Deadline for applications extended until 12 July 2013. The application deadline has been extended to enable applications by potential participants who have difficulties in funding their participation in the course. Negotiations are currently under way with the European Commission Joint Research Centre, which hosts the secretariat of the European Network of Cancer Registries (ENCR). If these negotiations are successful, it will be possible to sponsor selected participants, based on a separate application for funding. Read More |
| Former IARC staff member knighted for services to Public Health |
| 20/06/2013 - The International Agency for Research on Cancer (IARC) is proud to announce that former IARC staff member Dr Andrew (“Andy”) Hall was knighted in the United Kingdom, Queen’s Birthday Honours list 2013. Dr Hall, who recently retired as Professor of Epidemiology at the London School of Hygiene and Tropical Medicine, received the knighthood for services to public health. Dr Hall, who was an IARC staff member from 1986 to 1990, is best known at IARC as the first project leader of the Gambia Hepatitis Intervention Study (GHIS), and was stationed in The Gambia at that time. This innovative project, a collaboration between IARC, the Medical Research Council UK and The Gambian Government first sought to evaluate the efficacy of HBV vaccination through integration into the national Gambian Expanded Program on Immunization (EPI). This study is continuing long-term to look at the impact on the incidence of liver cancer through linkage to the national cancer registry established at that time. Dr Hall has continued to be involved in this project, even after he took up a position at the London School of Hygiene and Tropical Medicine, and he is currently a Senior Visiting Scientist at the Agency, where he keeps a close eye on the long-term follow-up of the children he helped immunize almost three decades ago. Congratulations, Sir Andy! Read more |
| Early HPV testing could detect sexually-transmitted oral cancer |
Antibodies to a high-risk type of human papillomavirus (HPV16) could help detect oropharyngeal cancer several years before the clinical onset of the disease, reveals a new study from the International Agency for Research on Cancer (IARC) in cooperation with the German Cancer Research Center (DKFZ) and the United States National Cancer Institute (NCI) in an article published online today by the Journal of Clinical Oncology. A R Kreimer, M Johansson, T Waterboer, R Kaaks, J Chang-Claude, D Drogen, A Tjønneland et al. Evaluation of Human Papillomavirus Antibodies and Risk of Subsequent Head and Neck Cancer Journal of Clinical Oncology published online on June 17, 2013; DOI: 10.1200/JCO.2012.47.2738 Read IARC Press Release 219 , Read article |
| 1st International Workshop on The Food Metabolome and Biomarkers for Dietary Exposure |
We are delighted to announce that the 1st International Workshop on “The Food Metabolome and Biomarkers for Dietary Exposure” will be held on 4–5 July 2013 at the 9th International Conference of the Metabolomics Society in Glasgow, Scotland. This workshop is co-organized by the International Agency for Research on Cancer (IARC), the French National Institute for Agricultural Research (INRA), University College Dublin (UCD), and the University of Glasgow. If you are interested in attending this workshop, please contact Dr Augustin Scalbert, Chair of the Organizing Committee, at scalberta@iarc.fr. Workshop Details |
| Emerging Oncogenic Viruses, 4 - 8 June 2014, San Pietro in Bevagna, Italy |
We are delighted to announce the 3rd Workshop on Emerging Oncogenic Viruses which will be held in San Pietro in Bevagna, Manduria, Italy, from 4 to 8 June 2014. This meeting is a joint IARC/DKFZ initiative, which will focus on discussions and the critical evaluation of epidemiology, immunology and biology of cancer-associated viruses. Visit website |
| IARC Publications - IARC Monographs in PDF |
| 29/05/2013 - Volume 103: Bitumens and Bitumen Emissions, and Some N- and S-Heterocyclic Polycyclic Aromatic Hydrocarbons. The Monograph is now available online. Download |
| EJC - Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012 - Now Available via Open Access |
J. Ferlay, E. Steliarova-Foucher, J. Lortet-Tieulent, S. Rosso, J.W.W. Coebergh, H. Comber, D. Forman, F. Bray. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. EJC, Volume 49, Issue 6, April 2013, Pages 1374–1403 Download PDF (available for 6 months) |
| IARC Training Courses: Paediatric Oncology for Cancer Registries |
| 24/05/2013 - Paediatric Oncology for Cancer Registries 25-29 November 2013 IARC, Lyon, France Deadline for applications is: 28 June 2013. Read More |
| New Training Course: Frontiers in Exposure Assessment in Epidemiology: Exposome |
| 21/05/2013 - A five-day course in the field of exposomics will take place in Florence from 16 to 21 June 2013. Two active members of IARC, Pietro Ferrari and Augustin Scalbert, will be joining the course faculty. Download programme , IARC Press Release 214 |
| Dr Christopher Wild re-elected as Director of IARC |
| 21/05/2013 - The International Agency for Research on Cancer (IARC) has the pleasure of announcing the re-election of Dr Christopher Wild as Director. Read IARC Press Release 218 |
| Brazil and Qatar join the International Agency for Research on Cancer |
| 16/05/2013 - Lyon, France – The International Agency for Research on Cancer (IARC) welcomed today two new participating member states. Brazil and Qatar are respectively the 23rd and 24th countries to join the cancer agency of the World Health Organization. Read IARC Press Release 217 , Portuguese version |
| World Cancer Report - Meet the Editors - Podcast |
| 14/05/2013 - The third edition of World Cancer Report is in preparation. Dr Christopher Wild, IARC Director, and Dr Bernard Stewart give a short preview of this new edition. Listen to Podcast |
| WHO Blue Books web site launched |
| 13/05/2013 - The International Agency for Research on Cancer (IARC) announces the launch of the WHO/IARC Classification of Tumours (WHO Blue Books) web site today. The WHO/IARC Classification of Tumours series establishes a pathological and genetic classification and grading of human tumours that is accepted and used worldwide. These authoritative, concise reference books provide an international standard for oncologists and pathologists and serve as indispensable guides for use in the design of studies monitoring response to therapy and clinical outcome. Diagnostic criteria, pathological features, and associated genetic alterations are described in a strictly disease-oriented manner. Sections on all recognized neoplasms and their variants include new International Classification of Diseases for Oncology (ICD-O) codes, epidemiology, clinical features, macroscopy, pathology, genetics, and prognosis and predictive factors. The new dedicated web site, http://whobluebooks.iarc.fr, presents the WHO Blue Books project to the scientific community through its public interface, including objective, historical perspective, news about the project, lists of volumes in the series, and other information. In particular, grateful acknowledgement is made of the invaluable contribution of the series editors, volume editors, and contributors who volunteered their time and expertise to help prepare the current (4th) edition of the WHO/IARC Classification of Tumours. Link to WHO Blue Books web site |
| IARC Postdoctoral Opportunities - Section of Environment and Radiation |
| 26/04/2013 - The Cancer and Environment Unit at Centre Léon Bérard and IARC’s Section of Environment and Radiation are conducting interdisciplinary research to investigate environmental and occupational causes of testicular germ cell tumors (with a focus on pesticides and endocrine disrupting chemicals) in case-control studies, including collection of biological specimens. Deadline: 17 May 2013 Read more |
| IARC Publications - IARC Monographs in PDF |
| 24/04/2013 - Volume 102: Non-Ionizing Radiation, Part 2: Radiofrequency Electromagnetic Fields. The Monograph is now available online. Download |
| Jin Young Park Receives 2013 Women in Cancer Research Scholar Award |
| 22/04/2013 - Jin Young Park, a postdoctoral fellow in the Dietary Exposure Assessment Group and the Prevention and Implementation Group at IARC, received a Women in Cancer Research Scholar Award at the 2013 Annual Meeting of the American Association for Cancer Research (AACR), held 6–10 April in Washington, DC. Read more , See Photos |
| Visit of Professor Dr Her Royal Highness Princess Chulabhorn Mahidol of Thailand |
IARC is pleased to welcome Professor Dr Her Royal Highness Princess Chulabhorn Mahidol of Thailand, who is visiting the Agency today to sign a cooperative agreement to stimulate academic interchange and foster high-quality collaborative research into the causes of human cancer. Read IARC Press Release 216 |
| Robert (Bob) MacLennan - 1931–2013 |
| 18/04/2013 - The International Agency for Research on Cancer (IARC) joins the international cancer community in mourning the passing, on 17 March 2013, of Robert (Bob) MacLennan. Read more , See photos |
| IARC in Biobanking and Biomolecular Resources Research Infrastructure partnership |
| 15/04/2013 - The International Agency for Research on Cancer (IARC) and the Biobanking and Biomolecular Resources Research Infrastructure (BBMRI) are joining forces to help create a worldwide frontline biobanking network. This 8M€ initiative, funded by the European Commission, involves 30 partners from 17 European countries and aims to stimulate scientific collaboration and enhance access to biosamples and large population cohorts. Link to BBMRI press release |
| IARC Postdoctoral Opportunities - Section of Nutrition and Metabolism / Biomarkers Group |
| 09/04/2013 - Call for applications for a postdoctoral opportunity within the Section of Nutrition and Metabolism / Biomarkers Group Deadline: 30 April 2013 Read more |
| Circulating antibodies to HPV16 E6 associated with oropharyngeal cancer risk |
At least 30% of cases of oropharyngeal cancer in Europe are human papillomavirus type 16 (HPV16)-related, reports a study led by scientists at the International Agency for Research on Cancer (IARC) and published online in the Journal of the National Cancer Institute on 16 March 2013. In the study, Dr Devasena Anantharaman and colleagues examined the association between the presence of circulating antibodies to type-specific HPV antigens and cancers of the upper aero-digestive tract. HPV16 E6 antibodies were specific to HPV16-related oropharyngeal cancers. Continuing efforts are needed to consider both HPV serology and p16 staining as biomarkers relevant to the etiology and natural history of HPV16-related oropharyngeal tumours, the study concluded. D Anantharaman, T Gheit, T Waterboer, B Abedi-Ardekani, C Carreira, S McKay-Chopin, V Gaborieau, M Marron, et al JNCI J Natl Cancer Inst (2013) doi: 10.1093/jnci/djt053 Read article |
| The Lancet Oncology - Carcinogenicity of polychlorinated biphenyls and polybrominated biphenyls |
In February 2013, 26 experts from 12 countries met at the International Agency for Research on Cancer (IARC), Lyon, France, to reassess the carcinogenicity of polychlorinated biphenyls (PCBs) and polybrominated biphenyls (PBBs). These assessments will be published as volume 107 of the IARC Monographs. B Lauby-Secretan, D Loomis, Y Grosse, F El Ghissassi, V Bouvard, L Benbrahim-Tallaa, N Guha, R Baan, H Mattock, K Straif, on behalf of the WHO IARC on Cancer Monograph Working Group The Lancet Oncology Published online March 15, 2013 DOl: S1470-2045(13)70104-9 Read more |
| IARC Postdoctoral Opportunities - Section of Environment and Radiation |
| 06/03/2013 - Call for applications for a postdoctoral/visiting scientist opportunity within the Section of Environment and Radiation Deadline: 31 March 2013 Read more |
| International Innovation - Research Highlights: IARC |
International Innovation - Research Highlights: IARC North America, March 2013 Drs Rolando Herrero, Silvia Franceschi and Rengaswamy Sankaranarayanan provide an overview of the pioneering work that is being conducted at IARC in an effort to beat cancer and save lives. They specifically focus on the research activities of the Prevention and Implementation Group, Infections and Cancer Epidemiology Group, and the Early Detection and Prevention Section and the Screening Group. Read more |
| EJC - Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012 |
J Ferlay, E. Steliarova-Foucher, J. Lortet-Tieulent, S. Rosso, J.W.W. Coebergh, H. Comber, D. Forman and F. Bray. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012 In Press, Corrected Proof, Eur J Cancer (2013) - Available online 26 February 2013, http://dx.doi.org/10.1016/j.ejca.2012.12.027 Read more , Read article |
| Joint WHO-IARC Statement in response to the recent Lancet report |
| 19/02/2013 - In response to IARC in the dock over ties with asbestos industry (The Lancet, doi:10.1016/S0140-6736(13)60152-X), WHO and IARC jointly correct false allegations and unfounded inferences. Read more |
| IARC contributes to Lancet Oncology Series highlighting the needs of children and young people with cancer |
A new Lancet Oncology Series presents the latest results and ideas from some of the world’s most eminent cancer experts from 19 countries spanning 6 continents. The Series aims to improve information availability, research, care, and education in the field of paediatric oncology and proposes a broad range of solutions for the next decade. Read more , The Lancet Oncology Series |
| Director of IARC: We need to act now to stop cancer |
| 18/02/2013 - Interview with Dr Christopher Wild, Director of IARC during his visit to the National Institute for Health and Welfare, Helsinki, Finland: We need to act now to stop cancer Read interview , See photo |
| IARC Training Courses - Statistical Practice in Epidemiology with R |
| 18/02/2013 - Statistical Practice in Epidemiology with R 23 to 29 May 2013 IARC, Lyon, France Deadline for applications is: 1 April 2013. Read more |
| JAMA – Risk of Recurrent Helicobacter pylori Infection 1 Year After Initial Eradication Therapy in 7 Latin American Communities |
As reported in JAMA this week, 1 year after treatment for Helicobacter pylori infection, recurrence occurred in 11.5% of the participants who had tested negative for H. pylori (using the UBT diagnostic procedure) after treatment. D Morgan, J Torres, R Sexton, R Herrero, E Salazar-Martínez, ER Greenberg, LE Bravo, et al. Risk of Recurrent Helicobacter pylori Infection 1 Year After Initial Eradication Therapy in 7 Latin American Communities JAMA. 2013;309(6):578-586. doi:10.1001/jama.2013.311 Read article , Full text |
| International Childhood Cancer Day 2013 |
| 14/02/2013 - IARC supports the campaign to raise worldwide public awareness of childhood cancer by observing International Childhood Cancer Day on 15 February. In particular, incidence, mortality, and survival data for childhood cancer produced at IARC in collaboration with population-based cancer registries around the world provide an indispensable resource for researchers and public health policy-makers. Read more |
| IARC Postdoctoral Opportunities - Section of Molecular Pathology |
| 13/02/2013 - Call for applications for a postdoctoral opportunity within the Section of Molecular Pathology Deadline: 30 April 2013 Read more |
| IARC Monographs Meeting - Volume 107: Polychlorinated biphenyls and polybrominated biphenyls |
| 11/02/2013 - Volume 107: Polychlorinated biphenyls and polybrominated biphenyls 12-19 February 2013 Lyon, France More information , Read Backgrounder |
| Meetings - 6th Inter-Cancéropôle Bioinformatics Workshop |
| 08/02/2013 - 6th Inter-Cancéropôle Bioinformatics Workshop 8 - 9 April 2013 Strasbourg, France The overall aim of this workshop is to discuss bioinformatic analysis of genomics based data, particularly data generated by next generation sequencing. More information , Provisional Program |
| Dr Margaret Chan, Director-General of the World Health Organization addresses staff at IARC |
| 05/02/2013 - On the occasion of World Cancer Day, 4 February 2013, Dr Margaret Chan, Director-General of the World Health Organization, paid a visit to the Agency, to discuss a number of strategic issues with the Director and his team. She gave an inspiring talk to all IARC Staff. This visit will be followed by the participation of the Director and Senior Staff at the retreat with Assistants Director-General on Friday, 8 February 2013. Full text of Dr Margaret Chan's address , See Photo Gallery |
| World Cancer Day 2013: Cancer - Did you know? |
As every year on 4 February, World Cancer Day, the World Health Organization (WHO) and the International Agency for Research on Cancer (IARC) support the Union for International Cancer Control (UICC) in promoting ways to reduce the global burden of cancer. “Did you know?” is the question posed for World Cancer Day 2013, which focuses on debunking damaging myths and misconceptions about the disease, reinforcing that there are still too many preconceived ideas about cancer that need demystifying and putting right. Prevention involves various approaches, and one aspect of this many-pronged effort, led by multiple agencies, is conveying clear messages to the public to improve general knowledge about cancer. Read more , IARC Press Release 215 |
| Senior Visiting Scientist Award 2012 |
| 28/01/2013 - The recipients of the 2012 highly competitive Senior Visiting Scientist Award, currently at IARC, are: Professor Isabel Dos Santos Silva from the Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK, Professor Terrence Dwyer from the Murdoch Childrens Research Institute, Royal Childrens Hospital, Parkville, VIC, Australia, and Professor Steven Rappaport from the Center for Occupational and Environmental Health, School of Public Health, University of California, Berkeley, Berkeley, CA, USA. Read more |
| IARC Publications - WHO Classification of Tumours of Soft Tissue and Bone. Fourth edition |
IARC WHO Classification of Tumours, No 5 Fletcher, C. D.M., Bridge, J.A., Hogendoorn, P., Mertens, F. This authoritative, concise reference book provides an international standard for oncologists and pathologists and will serve as an indispensable guide for use in the design of studies monitoring response to therapy and clinical outcome. Diagnostic criteria, pathological features, and associated genetic alterations are described in a strictly disease-oriented manner. Sections on all recognized neoplasms and their variants include new ICD-O codes, epidemiology, clinical features, macroscopy, pathology, genetics, and prognosis and predictive factors. Order at WHOPress |
| IARC renews key partnership with the National Cancer Centre of the Republic of Korea |
| 14/01/2013 - The IARC Director, Dr Christopher Wild, and the President of the National Cancer Centre of the Republic of Korea (NCC-RK), Dr Jin-Soo Lee, signed a new Memorandum of Understanding (MoU) on 14 January 2013 in Lyon, to further strengthen relations between the two organizations and broaden the scope of joint research activities and academic interchanges. Read more , See Photo Gallery |
| IARC to renew key partnership with the National Cancer Centre of the Republic of Korea |
| 11/01/2013 - The IARC Director, Dr Christopher Wild, and the President of the National Cancer Centre of the Republic of Korea (NCC-RK), Dr Jin-Soo Lee, will sign a new Memorandum of Understanding (MoU) on 14 January 2013 in Lyon, to further strengthen relations between the two organizations and broaden the scope of joint research activities and academic interchanges. Visit NCC-RK web site |
| IARC Publications - Improving Public Health Through Mycotoxin Control |
Improving Public Health Through Mycotoxin Control IARC Scientific Publication, No 158 Edited by JI Pitt, CP Wild, RA Baan, WCA Gelderblom, JD Miller, RT Riley and F Wu. This book aims to sensitize the international community to the mycotoxin problem in a format that is accessible to a wide audience and is useful to decision-makers across a broad spectrum of disciplines, including agriculture, public health, marketing, and economics. Order at WHOPress |